The microbiome—often called our “second brain”—affects nearly every process and system in the body.
And when it’s disrupted, it has a serious impact on our health.
THE REALITY
Common medical treatments like antibiotics and chemotherapy can disrupt the gut microbiome with a single dose.
This makes us more susceptible to serious health conditions, including infectious diseases.
THE PROBLEM WITH THE SOLUTION
The diverse gut microbiome from a healthy individual’s stool is used as a proven therapeutic. Unfortunately, processing a stool sample into oral capsules for therapeutic use is difficult, and the alternatives are invasive and expensive.
Introducing Tend
The health company that is making it radically easier for researchers, clinicians, and patients to access and understand the natural healing superpower of the gut microbiome.
the device that (simply) changes everything
Clean. Simple. Encapsulated.
Easily collect, prepare, and encapsulate the gut microbiome material in stool for approved therapeutic use.
Helping people heal from within—at a fraction of the time, cost, and effort.
When it comes to harnessing the potential of the gut microbiome, we have work to do. And we need your help.
We founded Tend to make it easier for researchers and clinicians to do the important work of treating patients today while also expanding the impact of the gut microbiome for patient healing tomorrow.
Interested in a better processing device for the gut microbiome for your patients, research, or clinical trial? We’d love to collaborate!
Latest posts
Mainstreaming the Microbiome
We happily publish and share relevant resources that give “the scoop on poop” and other news from around the fascinating world of the gut microbiome.
This information is not medical advice.
It is a collection of ideas and information about the emerging world of research, clinical trials, and news related to Tend and the gut microbiome.
DISCLAIMER
Patent Pending. Tend’s Gut Microbiome CAP device is not yet commercially available. While FMT is regulated by the FDA for the treatment of recurrent Clostridium difficile infection (C. diff.), the device has not been evaluated by the Food and Drug Administration. At this stage, the CAP device is only available for clinical trials and research. This product is not intended to diagnose, treat, cure, or prevent any disease, injury or condition. The CAP device is only intended to mix, filter and encapsulate a stool sample.